The We-Met platform beginned in 2015 at the Institute of Metabolic and Cardiovascular Diseases (I2MC) in Toulouse.

The aim of this platform has always been to provide the very latest innovative technologies and technical support around functional biochemistry.

Based on Alexandre Lucas's skills in biochemistry, the platform provides 3 major poles of technologies : around western blot, around biomarkers and the study of cell metabolism by Seahorse analyser.

 

CONTACTEZ-NOUS